The Risks of Splitting the MMR Vaccine: Historical Insights and Implications
Splitting the MMR vaccine could lead to missed doses and increased illness among children, echoing past lessons from vaccine history.
August 11, 2026
Technology
Latest technology news and innovations
FDA Rejection Hits Radiopharma; Hims & Hers Eyes Peptides Market
FDA nixes a radiopharma drug by ITM Isotope Technologies, while Hims & Hers plans to enter the peptides market amidst evolving regulations.
August 11, 2026
Skylark Bio Launches Gene Therapy Trial Targeting GJB2-Related Deafness
Skylark Bio has initiated a clinical trial aimed at treating hearing loss in children with GJB2 mutations, following advancements in gene therapy.
August 11, 2026
The Shift in Abortion Care: A Move Towards Digital Support
Abortion care is evolving, with patients increasingly turning to digital solutions for reliable information and medical guidance.
August 11, 2026
MoonLake Immunotherapeutics' Ambiguous Data Raises Concerns in Drug Development
MoonLake Immunotherapeutics faces scrutiny for vague disclosures on its autoimmune drug candidate, raising questions about its trial results’ credibility.
August 11, 2026
Nurses Advocate for Involvement in Clinical AI Development Amid Growing Concerns
Nurses are increasingly spotlighting the risks of clinical AI, advocating for a collaborative approach to its development and deployment in healthcare.
August 11, 2026
Challenges Ahead for Medicare's New GLP-1 Weight Loss Drug Program
Medicare's “Bridge” program aims to lower costs for GLP-1 medications, yet its complexity may hinder patient access to affordable treatments.
August 11, 2026
FDA Denies Approval for ITM-11, a Radiopharmaceutical Therapy Set to Compete with Novartis
The FDA has rejected ITM-11 due to manufacturing concerns, hindering its potential as a competitor to Novartis’ treatment for rare neuroendocrine tumors.
August 10, 2026
New FDA Requirements on Food Additives Demand Transparency from Manufacturers
The FDA now requires manufacturers to disclose food additive details, enhancing oversight for substances previously lacking regulation.
August 10, 2026
Dissecting the Debate on Covid-19's Origins Amid Political Turmoil
The recent Senate hearings on Covid-19's origins spotlight political distractions, while China's suppression of information remains a pivotal issue.
August 07, 2026
NIH Decision Could Hinder International Researchers' Opportunities in Biomedical Fields
The NIH's proposed changes to funding eligibility may limit opportunities for international researchers on visas in the U.S. biomedical sector.
August 07, 2026
Replimune’s Melanoma Drug Approved Amid Medicare Policy Shift Impacting Price Negotiations
Replimune's new melanoma treatment gains FDA approval, while a Medicare policy change delays price negotiations for AbbVie drugs.
August 07, 2026
Boston's Biotech Scene Faces New Challenges Amid a Changing Landscape
As Boston's biotech sector grapples with talent migration to California, new discoveries in Alzheimer's research signal both change and opportunity.
August 07, 2026
AI’s Role in Medicine: Eroding Physician Autonomy or an Opportunity for Reflection?
As AI tools proliferate in healthcare, the erosion of physician autonomy raises questions about clinical judgment, responsibility, and professional independence.
August 07, 2026
Why a Boston-Bred Biotech Founder Chose California for His Startup
Felix Wong's biotech startup thrives in California's culture despite his Massachusetts roots and impressive academic pedigree.
August 07, 2026
Replimune's Tumultuous Journey Ends with FDA Approval of Melanoma Treatment
Replimune's advanced melanoma drug, RP1, receives FDA approval after a challenging path, bringing hope to patients with a hefty price tag.
August 06, 2026
Medicare's Policy Shift Delays Price Negotiations for Key AbbVie Drug
A recent Medicare policy change has postponed the price negotiations for a major AbbVie drug, potentially impacting taxpayers significantly.
August 06, 2026
New Insights into Tau's Role in Alzheimer's Open Doors for Potential Treatments
A recent study reveals tau protein’s unexpected influence on cellular function, suggesting novel strategies for Alzheimer’s treatment.
August 06, 2026
FDA Grants Approval for New Drug and Vaccine, Impacting Biotech Landscape
The FDA has recently approved a new therapeutic drug and a vaccine, shaping the future direction of biotechnology and addressing pressing health needs.
August 06, 2026
FDA Approval of Takeda's Orzeyful Marks a Shift in Narcolepsy Treatment
The FDA has approved Takeda's Orzeyful, a new orexin receptor agonist that promises to improve daytime alertness for narcolepsy patients.
August 05, 2026